PAR PHARMACEUTICAL COMPANIES, INC. Earnings Per Share (Basic)
PAR PHARMACEUTICAL COMPANIES, INC. reported Earnings Per Share (Basic) of $1.41 per share for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2012-08-02
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for the quarter ending 2012-06-30 was $1.41, a 464.00% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for the quarter ending 2012-03-31 was -$0.79.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for the quarter ending 2011-12-31 was $1.44, a 188.00% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for the quarter ending 2011-09-30 was $0.61, a 31.46% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for fiscal 2011 was -$0.73, a 127.04% decline from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for fiscal 2010 was $2.70, a 18.42% increase from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, basic for fiscal 2009 was $2.28.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2012-06-30 | $1.41 10-Q · filed 2012-08-02 | $0.62 10-Q · filed 2012-08-02 | $2.05 derived: net income ÷ weighted average shares · filed 2012-08-02 | $2.66 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2012-03-31 | -$0.79 10-Q · filed 2012-05-08 | $0.64 derived: net income ÷ weighted average shares · filed 2012-05-08 | $1.24 derived: net income ÷ weighted average shares · filed 2012-05-08 | $1.50 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-12-31 | $1.44 10-K · filed 2012-02-28 | $2.04 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.29 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$0.73 10-K · filed 2012-02-28 |
| 2011-09-30 | $0.61 10-K · filed 2012-02-28 | $0.86 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$2.17 10-Q · filed 2011-11-02 | -$1.70 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-06-30 | $0.25 10-Q · filed 2012-08-02 | -$2.80 10-Q · filed 2012-08-02 | -$2.32 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$1.48 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-03-31 | -$3.07 10-Q · filed 2012-05-08 | -$2.60 derived: net income ÷ weighted average shares · filed 2012-05-08 | -$1.75 derived: net income ÷ weighted average shares · filed 2012-05-08 | -$1.23 derived: net income ÷ weighted average shares · filed 2012-05-08 |
| 2010-12-31 | $0.50 10-K · filed 2012-02-28 | $1.39 derived: net income ÷ weighted average shares · filed 2012-02-28 | $1.93 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.70 10-K · filed 2012-02-28 |
| 2010-09-30 | $0.89 10-K · filed 2012-02-28 | $1.43 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.20 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $0.54 10-K · filed 2012-02-28 | $1.32 10-Q · filed 2011-08-03 | ||
| 2010-03-31 | $0.78 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $2.28 10-K · filed 2012-02-28 |